Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of California at Los Angeles - UCLA
mi
from
Los Angeles, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of California at Los Angeles - UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Colorado Cardiac and Vascular Center
mi
from
Aurora, CO
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Colorado Cardiac and Vascular Center
mi
from
Aurora, CO
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Cleveland Clinic Florida
mi
from
Weston, FL
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
The Emory Clinic
mi
from
Atlanta, GA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Chicago
mi
from
Chicago, IL
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Lsu Health Sciences Center
mi
from
New Orleans, LA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Lsu Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Maryland Medical Center Division of Cardiology
mi
from
Baltimore, MD
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Maryland Medical Center Division of Cardiology
mi
from
Baltimore, MD
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Boston University Medical Center
mi
from
Boston, MA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Brigham and Women's Hosp
mi
from
Boston, MA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Tufts Medical Center
mi
from
Boston, MA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Michigan
mi
from
Ann Arbor, MI
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Univ of Minnesota
mi
from
Minneapolis, MN
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Mary M Parkes Center
mi
from
Rochester, NY
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Mary M Parkes Center
mi
from
Rochester, NY
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Ohio State University Martha Morehouse Medical Pavilion
mi
from
Columbus, OH
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Ohio State University Martha Morehouse Medical Pavilion
mi
from
Columbus, OH
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Baylor College of Medicine
mi
from
Houston, TX
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Scott & White Memorial Hospital
mi
from
Temple, TX
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of California at San Francisco
mi
from
San Francisco, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
The Mayo Clinic
mi
from
Rochester, MN
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Washington University School of Medicine
mi
from
St. Louis, MO
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Alberta Health Services
mi
from
Calgary,
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Alberta Health Services
mi
from
Calgary,
Click here to add this to my saved trials
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement: Continuous Intracranial Pressure Monitoring Subprotocol
Status: Enrolling
Updated:  10/20/2015
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement: Continuous Intracranial Pressure Monitoring Subprotocol
Status: Enrolling
Updated: 10/20/2015
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Medication Adherence With Polyglot Meducation
Evaluate Changes in Medication Adherence and Patient Perspective of Polyglot Systems, Inc's Meducation Technology
Status: Enrolling
Updated:  10/22/2015
Durham VA Medical Center
mi
from
Durham, NC
Medication Adherence With Polyglot Meducation
Evaluate Changes in Medication Adherence and Patient Perspective of Polyglot Systems, Inc's Meducation Technology
Status: Enrolling
Updated: 10/22/2015
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Arizona Heart Rhythm Research Center
mi
from
Phoenix, AZ
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Arizona Heart Rhythm Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
University of Southern California
mi
from
Los Angeles, CA
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
George Washington University
mi
from
Washington,
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Florida Hospital and Cardiovascular Institute
mi
from
Orlando, FL
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Florida Hospital and Cardiovascular Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Florida Cardiovascular Institute
mi
from
Tampa, FL
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Florida Cardiovascular Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Cardiovascular Institute of the South
mi
from
Houma, LA
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Cardiovascular Institute of the South
mi
from
Houma, LA
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Cardiac and Vascular Research Center of Northern Michigan
mi
from
Petosky, MI
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Cardiac and Vascular Research Center of Northern Michigan
mi
from
Petosky, MI
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Michigan Cardiovascular Institute
mi
from
Saginaw, MI
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Michigan Cardiovascular Institute
mi
from
Saginaw, MI
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Aspirus Wausau Hospital
mi
from
Wausau, WI
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Aspirus Wausau Hospital
mi
from
Wausau, WI
Click here to add this to my saved trials
Combined Renin Inhibition/Beta-blockade
Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade
Status: Enrolling
Updated:  10/26/2015
The Rogosin Institute
mi
from
New York, NY
Combined Renin Inhibition/Beta-blockade
Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade
Status: Enrolling
Updated: 10/26/2015
The Rogosin Institute
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults
Effects of Milk Protein Concentrate on Blood Pressure, Inflammation, Muscle Health During Weight Loss in Overweight/Obese Adults
Status: Enrolling
Updated:  11/3/2015
Purdue University - Stone Hall 700 W State St
mi
from
W Lafayette, IN
Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults
Effects of Milk Protein Concentrate on Blood Pressure, Inflammation, Muscle Health During Weight Loss in Overweight/Obese Adults
Status: Enrolling
Updated: 11/3/2015
Purdue University - Stone Hall 700 W State St
mi
from
W Lafayette, IN
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
Yale Cancer Center
mi
from
New Haven, CT
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
Yale Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
VA Medical Center West Haven
mi
from
West Haven, CT
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
VA Medical Center West Haven
mi
from
West Haven, CT
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
Brigham and Women's
mi
from
Boston, MA
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
Brigham and Women's
mi
from
Boston, MA
Click here to add this to my saved trials